Isuprel

Isuprel

Clinical data
Routes of administration	inhaled 80-120μg
ATC code	C01CA02 (WHO) R03AB02 (WHO)
Identifiers
IUPAC name 4-[1-hydroxy-2-(1-methylethylamino) ethyl] benzene-1,2-diol
CAS Number	7683-59-2
PubChem CID	3779
DrugBank	APRD00182
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C11H17NO3
Molar mass	211.258 g/mol

Isoproterenol hydrochloride or isoprenaline (Medihaler-Iso®) is a sympathomimetic beta adrenergic receptor agonist medication.

It is structurally similar to epinephrine but acts for the most part on beta receptors.

Uses

It is used as an inhaled aerosol to treat asthma. Although it activates all beta adrenergic receptors, it works in a similar fashion to the more selective beta2-adrenergic receptor agonists e.g. salbutamol, by relaxing the airways to increase airflow.

It is also supplied in ampules under the brand name Isuprel® for injection and in sublingual pill form for treatment of asthma, chronic bronchitis and emphysema.

Used with caution, it can also be used to treat torsades de pointes, in conjunction with overdrive pacing and magnesium.

Pharmacology

Isoproterenol is a β₁- and β₂-adrenoceptor agonist which was commonly used to treat asthma before the more widespread use of salbutamol, which has more selective effects on the airways. Its route of administration is either intravenous, oral, intranasal, subcutaneous, or intramuscular, depending on use. The plasma half-life for isoproterenol is approximately two hours.

Isoproterenol's effects on the cardiovascular system relate to its actions on cardiac β₁ receptors and β₂ receptors on skeletal muscle arterioles. Isoproterenol has positive inotropic and chronotropic effects on the heart. In skeletal muscle arterioles it produces vasodilatation. Its inotropic and chronotropic effects elevate systolic blood pressure, while its vasodilatory effects tend to lower diastolic blood pressure.

The adverse effects of isoproterenol are also related to the drug's cardiovascular effects. Isoproterenol can produce an elevated heart rate (tachycardia), which predisposes patients to cardiac dysrhythmias.

Warnings and Contraindications

Isoproterenol should not be administered to patients with myocardial ischaemia.

Template:Pharma-stub